血管素和急性损伤在败血症患者之间的相关性
1Department of Mental Health, The First Hospital of Hebei Medical University, Shijiazhuang, China. yangxiufen516@sina.com.
European review for medical and pharmacological sciences
|December 1, 2023
概括
在患有急性损伤 (AKI) 的败血症患者中,血管新素-1 (Ang-1) 水平较高,而Ang-2/Ang-1比率较低. 这些血管激素变化与功能相关,这表明它们在AKI风险评估中的潜在作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
- 生物化学 生物化学
背景情况:
- 败血症是一种危及生命的器官功能障碍,是由宿主对感染的反应失调引起的.
- 急性损伤 (AKI) 是败血症的常见和严重并发症.
- 血管新生素 (Ang) 在败血症相关的AKI (SA-AKI) 中的作用需要进一步阐明.
研究的目的:
- 调查AKI和无AKI的败血症患者Ang-1和Ang-2水平的变化.
- 评估Ang水平与功能之间的关系,特别是质过率 (GFR).
- 确定Ang的潜力作为AKI在败血症风险的生物标志物.
主要方法:
- 对66名进入ICU的败血症患者进行前性研究.
- 患者被分为与败血症相关的AKI (SA-AKI) 和非AKI组.
- 血Ang-1和Ang-2水平的比较,并计算两组之间的Ang-2/Ang-1比率.
- 对Ang水平和GFR之间的相关性分析.
主要成果:
- 与非AKI组相比,SA-AKI组的血Ang-1水平明显高于非AKI组 (p=0.039).
- 在SA-AKI组中,Ang-2/Ang-1比率明显较低 (p=0.001).
- Ang-1与GFR呈负相关性 (r=-0.12,p=0.031),而Ang-2和Ang-2/Ang-1比率与GFR呈正相关性 (分别r=0.204,p<0.001和r=0.21,p<0.001).
结论:
- 血Ang-1和Ang-2水平,特别是它们的比率,在AKI的败血症患者中发生变化.
- 这些Ang变异与功能受损 (较低的GFR) 有关.
- Ang水平可以作为评估毒症患者AKI风险的指标.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654
Antihypertensive Drugs: Direct Renin Inhibitors
637
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
637
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K


